No Data
No Data
10-Q: Quarterly report
LIGAND PHARMACEUTICAL INC (LGNXZ.US) will release its financial report before the market opens on November 7th.
$LIGAND PHARMACEUTICAL INC (LGNXZ.US)$ will release its financial report before the market opens on November 7th. Investors are kindly requested to pay attention. Futubull reminder: 1. There is no strict regulation on the accounting year division time for Hong Kong-listed and U.S.-listed companies, it is completely determined by the companies themselves. Therefore, each financial report period can serve as the company's annual report deadline, rather than using the calendar year as the fiscal year. 2. Generally, the company will hold the financial report conference on the above report release date or around that date, where the company management will discuss the latest quarterly financial data and operational situation.
10-Q: Q2 2024 Earnings Report
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 446.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 194.71K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 505.15K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
No Data
No Data